IJR News — today's news from every side
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
Loading
Genius — OpenServe
News
Home
Popular
Elections
Genius — OpenServe
Trending
'Can I Pray for You' Is the Last Thing Speeding Woman Expected to Hear from Officer
Reporting
— Jul 3, 2022
A chance encounter on a North Carolina highway showed the power of faith to transform random events into powerful moments. The bare facts are simple. In March, North Carolina State Highway Patrol Trooper Jaret Doty…
0
Share
Crystalys Therapeutics raises $130M Series B
x/united-states-of-america
— Jul 22, 2026
Crystalys Therapeutics has raised a $130 million Series B led by Frazier Life Sciences with participation from multiple investors to fund late-stage global trials and commercialization plans for dotinurad, its URAT1 inhibitor for gout. The financing backs the RUBY, TOPAZ, and AMETHYST studies and aims to accelerate regulatory milestones and commercial readiness across the U.S. and Europe as the company positions dotinurad as a best-in-class option between first-line therapies and last-line treatments.
+4
0
Share